1. Home
  2. AXSM vs ESGR Comparison

AXSM vs ESGR Comparison

Compare AXSM & ESGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXSM
  • ESGR
  • Stock Information
  • Founded
  • AXSM 2012
  • ESGR 2001
  • Country
  • AXSM United States
  • ESGR Bermuda
  • Employees
  • AXSM N/A
  • ESGR N/A
  • Industry
  • AXSM Biotechnology: Pharmaceutical Preparations
  • ESGR Property-Casualty Insurers
  • Sector
  • AXSM Health Care
  • ESGR Finance
  • Exchange
  • AXSM Nasdaq
  • ESGR Nasdaq
  • Market Cap
  • AXSM 4.8B
  • ESGR 4.7B
  • IPO Year
  • AXSM 2015
  • ESGR N/A
  • Fundamental
  • Price
  • AXSM $104.46
  • ESGR $334.01
  • Analyst Decision
  • AXSM Strong Buy
  • ESGR
  • Analyst Count
  • AXSM 15
  • ESGR 0
  • Target Price
  • AXSM $171.00
  • ESGR N/A
  • AVG Volume (30 Days)
  • AXSM 912.2K
  • ESGR 131.5K
  • Earning Date
  • AXSM 05-05-2025
  • ESGR 05-01-2025
  • Dividend Yield
  • AXSM N/A
  • ESGR N/A
  • EPS Growth
  • AXSM N/A
  • ESGR N/A
  • EPS
  • AXSM N/A
  • ESGR 35.90
  • Revenue
  • AXSM $385,693,000.00
  • ESGR $1,205,000,000.00
  • Revenue This Year
  • AXSM $63.85
  • ESGR N/A
  • Revenue Next Year
  • AXSM $63.93
  • ESGR N/A
  • P/E Ratio
  • AXSM N/A
  • ESGR $9.30
  • Revenue Growth
  • AXSM 42.53
  • ESGR 3.35
  • 52 Week Low
  • AXSM $64.11
  • ESGR $276.32
  • 52 Week High
  • AXSM $139.13
  • ESGR $348.48
  • Technical
  • Relative Strength Index (RSI)
  • AXSM 41.94
  • ESGR 59.68
  • Support Level
  • AXSM $86.99
  • ESGR $331.05
  • Resistance Level
  • AXSM $103.75
  • ESGR $335.00
  • Average True Range (ATR)
  • AXSM 5.84
  • ESGR 1.95
  • MACD
  • AXSM -0.01
  • ESGR 0.11
  • Stochastic Oscillator
  • AXSM 56.74
  • ESGR 87.84

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

About ESGR Enstar Group Limited

Enstar Group Ltd is a (re)insurance group that offers capital release solutions through its network of group companies. It seeks to create value by managing (re)insurance companies and portfolios of (re)insurance and other liability businesses in run-off and striving to generate an attractive risk-adjusted return from its investment portfolio. Its operations are through four reportable segments: Run-off, Assumed Life, Investments, and Legacy Underwriting.

Share on Social Networks: